Stay updated on Subcutaneous ND0612 Infusion in Parkinson's Clinical Trial

Sign up to get notified when there's something new on the Subcutaneous ND0612 Infusion in Parkinson's Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Subcutaneous ND0612 Infusion in Parkinson's Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The new screenshot shows layout and styling changes without changes to the trial's core details such as eligibility, locations, or enrollment.
    Difference
    0.4%
    Check dated 2025-11-03T21:13:38.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    29 days ago
    Change Detected
    Summary
    Major update: operating-status notice and new version v3.2.0; old v3.1.0 reference removed.
    Difference
    5%
    Check dated 2025-10-06T05:52:07.000Z thumbnail image
  4. Check
    36 days ago
    Change Detected
    Summary
    Page now shows revision to v3.1.0 and removes several drug-safety-related topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) from the content, indicating a shift away from those topics while adding a new version.
    Difference
    0.6%
    Check dated 2025-09-29T03:11:07.000Z thumbnail image
  5. Check
    50 days ago
    Change Detected
    Summary
    Release updated from v3.0.1 to v3.0.2. The Back to Top element has been removed.
    Difference
    0.3%
    Check dated 2025-09-14T21:39:24.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1.
    Difference
    0.3%
    Check dated 2025-09-07T18:04:53.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location, as well as new topics related to drug safety and Parkinson's disease. Notably, several specific drug-related terms and categories have been added, while previous entries related to certain drugs and their classifications have been removed.
    Difference
    5%
    Check dated 2025-08-31T12:16:18.000Z thumbnail image

Stay in the know with updates to Subcutaneous ND0612 Infusion in Parkinson's Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Subcutaneous ND0612 Infusion in Parkinson's Clinical Trial page.